Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design

Karim Fizazi, Stéphanie Foulon, Joan Carles, Guilhem Roubaud, Ray McDermott, Aude Fléchon, Bertrand Tombal, S. Supiot, Dominik Berthold, Philippe Ronchin, Gabriel Kacsó, Gwénaëlle Gravis, Fabio Calabrò, Jean-François Berdah, Ali Hasbini, Marlon Silva, Antoine Thiery-Vuillemin, I. Latorzeff, Loı̈c Mourey, Brigitte Laguerre, Sophie Abadie‐Lacourtoisie, É. Martin, Claude El Kouri, Anne Escande, A Soler Roselló, Nicolas Magné, Friederike Schlürmann, Frank Priou, Marie-Eve Chand-Fouché, Salvador Villà Freixa, Muhammad Jamaluddin, Isabelle Rieger, Alberto Bossi